Clinical Trial Update: ALTO-100 in Bipolar Disorder With Depression (BD-D) [Phase 2]

View source ↗

Summary

ALTO-100 is in Phase 2 and currently recruiting for bipolar disorder with a major depressive episode (BD-D).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• ALTO-100

Snippet

Sponsor: Alto Neuroscience | Conditions: Bipolar Disorder I or II With a Major Depressive Episode | Phase 2 | Status: RECRUITING